Saint-Herblain (France), September 30, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported positive antibody persistence data four years after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback